RAD MIDTERM 1 TCDHA COMPREHENSIVE STUDY GUIDE
2026 FULL QUESTIONS AND SOLUTIONS GRADED A+
● Latent Period. Answer: Symptom-free interval
● Prodromal Syndrome. Answer: Early symptoms
● Manifest Illness. Answer: Full symptoms
● Recovery or Death. Answer: Final stage
● LD 50/30. Answer: Lethal dose 50% in 30 days
● Skin Effects. Answer: Erythema desquamation
● Cataractogenesis. Answer: Lens opacity
● Gonadal Dose. Answer: Reproductive organ exposure
● Fetal Dose. Answer: Unborn exposure
● Embryo. Answer: Early development stage
● Fetus. Answer: Later development stage
● Organogenesis. Answer: Organ formation
● Major Organogenesis. Answer: Critical period
● First Trimester. Answer: Weeks 1-12
● Second Trimester. Answer: Weeks 13-26
● Third Trimester. Answer: Weeks 27-40
● Shielding. Answer: Protective barrier
● Lead Apron. Answer: Body shield
● Thyroid Shield. Answer: Neck protection
2026 FULL QUESTIONS AND SOLUTIONS GRADED A+
● Latent Period. Answer: Symptom-free interval
● Prodromal Syndrome. Answer: Early symptoms
● Manifest Illness. Answer: Full symptoms
● Recovery or Death. Answer: Final stage
● LD 50/30. Answer: Lethal dose 50% in 30 days
● Skin Effects. Answer: Erythema desquamation
● Cataractogenesis. Answer: Lens opacity
● Gonadal Dose. Answer: Reproductive organ exposure
● Fetal Dose. Answer: Unborn exposure
● Embryo. Answer: Early development stage
● Fetus. Answer: Later development stage
● Organogenesis. Answer: Organ formation
● Major Organogenesis. Answer: Critical period
● First Trimester. Answer: Weeks 1-12
● Second Trimester. Answer: Weeks 13-26
● Third Trimester. Answer: Weeks 27-40
● Shielding. Answer: Protective barrier
● Lead Apron. Answer: Body shield
● Thyroid Shield. Answer: Neck protection
